Symbol="EXEL"
AssetType="Common Stock"
Name="Exelixis Inc"
Description="Exelixis, Inc., an oncology-focused biotechnology company, is focused on the discovery, development, and commercialization of new drugs to treat cancers in the United States. The company is headquartered in Alameda, California."
CIK="939767"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="TRADE & SERVICES"
Industry="SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH"
Address="1851 HARBOR BAY PARKWAY, ALAMEDA, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="6288050000"
EBITDA="170311000"
PERatio="40.23"
PEGRatio="0.316"
BookValue="7.86"
DividendPerShare="0"
DividendYield="0"
EPS="0.48"
RevenuePerShareTTM="5.16"
ProfitMargin="0.0924"
OperatingMarginTTM="0.0884"
ReturnOnAssetsTTM="0.0317"
ReturnOnEquityTTM="0.0634"
RevenueTTM="1663870000"
GrossProfitTTM="1553153000"
DilutedEPSTTM="0.48"
QuarterlyEarningsGrowthYOY="-0.429"
QuarterlyRevenueGrowthYOY="0.148"
AnalystTargetPrice="25.4"
TrailingPE="40.23"
ForwardPE="10.58"
PriceToSalesRatioTTM="3.111"
PriceToBookRatio="2.042"
EVToRevenue="2.258"
EVToEBITDA="9.66"
Beta="0.67"
num_52WeekHigh="22.15"
num_52WeekLow="14.87"
num_50DayMovingAverage="19.2"
num_200DayMovingAverage="17.63"
SharesOutstanding="325637000"
DividendDate="None"
ExDividendDate="None"
symbol="EXEL"
open="19.42"
high="19.56"
low="19.17"
price="19.31"
volume="1404977.00"
latest_trading_day="2023-07-07"
previous_close="19.33"
change="-0.02"
change_percent="-0.1035%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="11"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="89"
Volume_recent_avg="2929231"
Change_recent_avg="0.02"
Delta_recent_avg="0.42"
Variance_recent_avg="0.21"
Change_ratio_recent_avg="0.11"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="89"
Aroon_momentum_negative="11"
image_negative_thumbnail_id_1="1089"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0122.jpeg"
image_negative_thumbnail_id_2="163"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0013.jpeg"
image_neutral_thumbnail_id_1="542"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0057.jpeg"
image_neutral_thumbnail_id_2="573"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0026.jpeg"
image_positive_thumbnail_id_1="978"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0140.jpeg"
image_positive_thumbnail_id_2="1014"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0176.jpeg"
image_professor_thumbnail_id_1="1181"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0015.jpeg"
image_professor_thumbnail_id_2="1174"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
